Gerharz C D, Moll R, Störkel S, Ramp U, Hildebrandt B, Molsberger G, Koldovsky P, Gabbert H E
Institute of Pathology, University Hospital of Düsseldorf, Germany.
Am J Pathol. 1995 Apr;146(4):953-62.
The chromophobe renal cell carcinoma is a distinct type of renal cancer presumably derived from the intercalated cell of the collecting duct system and exhibiting a better prognosis than other types of renal cell carcinoma. Chromophobe carcinomas can be separated from other types of renal cell carcinoma by their characteristic cytomorphology, ultrastructural appearance, cytoskeletal architecture, and cytogenetic aberrations. As no permanent cell line of the chromophobe tumor type has previously been described, we are the first to report on the successful establishment and characterization of two divergent permanent cell lines, ie, chrompho-A and chrompho-B, derived from the same chromophobe renal cell carcinoma. With immunocytochemistry, two-dimensional gel electrophoresis, and Western blot, chrompho-A and chrompho-B exclusively exhibited cytokeratins (Nos. 7, 8, 18, and 19) but not vimentin. Ultrastructural studies revealed numerous cytoplasmic microvesicles as well as coated vesicles that are known to be characteristic features of the intercalated cell. Chrompho-B cells exhibited a shorter mean population doubling time (tD = 43 hours) than chrompho-A cells (tD = 51 hours). Both cell lines failed to produce tumors in nude mice with the subrenal capsule assay. Cytogenetic analyses revealed hyperdiploid chromosome numbers in both cell lines with telomeric associations as well as numeric aberrations known from chromophobe renal cell carcinomas in vivo.
嫌色性肾细胞癌是一种独特类型的肾癌,推测起源于集合管系统的闰细胞,与其他类型的肾细胞癌相比预后较好。嫌色性癌可通过其特征性的细胞形态学、超微结构表现、细胞骨架结构和细胞遗传学异常与其他类型的肾细胞癌区分开来。由于此前尚未描述过嫌色性肿瘤类型的永久性细胞系,我们首次报告成功建立并鉴定了源自同一例嫌色性肾细胞癌的两个不同的永久性细胞系,即嫌色-A和嫌色-B。通过免疫细胞化学、二维凝胶电泳和蛋白质印迹法,嫌色-A和嫌色-B仅表达细胞角蛋白(7、8、18和19号),而不表达波形蛋白。超微结构研究显示有大量胞质微泡以及包被小泡,这些都是闰细胞的特征性表现。嫌色-B细胞的平均群体倍增时间(tD = 43小时)比嫌色-A细胞(tD = 51小时)短。在裸鼠肾被膜下接种试验中,这两种细胞系均未产生肿瘤。细胞遗传学分析显示,这两种细胞系的染色体数目均为超二倍体,存在端粒联合以及体内嫌色性肾细胞癌已知的数目异常。